Equity · Healthcare
IDXX
NASDAQIDEXX Laboratories (IDXX)
The line runs 560 USD on 24 August through 676.76 USD on 20 November, on a scale from 500 to 800. Days the market did not trade hold the previous close, flat.
- Market cap
- 53.3B USD
- P/E (TTM)
- 45.6
- Revenue, year to Dec 2025
- 4.3B USD
- EPS, diluted, year to Dec 2025
- 13.08 USD
- 52-week range
- 505 USD – 766.67 USD
- Avg volume
- 38.2K
- Mentions, 30 days
- 1
as of Nov 20, 2026
Have IDEXX Laboratories (IDXX) insiders bought or sold shares recently?
In the 90 days to 22 Nov 2026, IDEXX Laboratories insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 14 Feb 2026, show no open-market purchase.
Form 4, 90 days to 22 Nov 2026, newest reported trade 4 Nov 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 04 Nov 2026 | JUNIUS DANIEL MDirector | Sell | 1,200 | 845K USD |
| 04 Nov 2026 | Lane MichaelExecutive Vice President | Sell | 3,979 | 2.7M USD |
| 04 Nov 2026 | MAZELSKY JONATHAN JAYExecutive Chair of the Board | Sell | 25,140 | 17.7M USD |
| 04 Nov 2026 | Underberg Sharon E.EVP, GC & Corporate Secretary | Sell | 8,906 | 6.1M USD |
| 04 Sep 2026 | Kingsley Lawrence DDirector | Sell | 2,203 | 1.2M USD |
| Sold | 5 open-market sales | 41,428 | $28.57M |
7 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 18 Nov 2026 | Lane MichaelExecutive Vice President | Option exercise | 863 | 299K USD |
| 16 Nov 2026 | MAZELSKY JONATHAN JAYExecutive Chair of the Board | Gift | 700 | |
| 10 Nov 2026 | FENNELL GEORGEExecutive Vice President | Option exercise | 1,749 | 300K USD |
| 04 Nov 2026 | MAZELSKY JONATHAN JAYExecutive Chair of the Board | Option exercise | 25,140 | 4.5M USD |
| 04 Nov 2026 | Underberg Sharon E.EVP, GC & Corporate Secretary | Option exercise | 8,906 | 2.6M USD |
| 30 Oct 2026 | HOOLEY JOSEPH LDirector | Award | 48 | 26K USD |
| 04 Sep 2026 | Kingsley Lawrence DDirector | Option exercise | 2,203 | 252K USD |
Which funds hold IDEXX Laboratories (IDXX)?
12 of the 45 institutional funds we track reported a IDEXX Laboratories position for the quarter ended 30 Sep 2026 — a combined 892.5M USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fundsmith | Trimmed | 714,883 | 373.3M USD | −29.9% |
| Millennium Management | Added | 306,290 | 159.9M USD | +287.8% |
| Point72 Asset Management | Trimmed | 173,958 | 90.8M USD | −33.8% |
| Renaissance Technologies | Held (±25%) | 109,644 | 57.3M USD | −0.1% |
| Citadel Advisors | Added | 101,626 | 53.1M USD | +161.6% |
| AQR Capital Management | Held (±25%) | 85,688 | 44.7M USD | +11.0% |
| Man Group | Added | 69,245 | 36.2M USD | +34.8% |
| Balyasny Asset Management | Added | 58,837 | 30.7M USD | +3,154.3% |
| Marshall Wace | Trimmed | 48,273 | 25.2M USD | −48.2% |
| Bridgewater Associates | Held (±25%) | 38,921 | 20.3M USD | +16.1% |
Showing the 10 largest of 12 reported positions. The figures above count all of them.
Have members of Congress traded IDEXX Laboratories (IDXX)?
The most recent congressional trade disclosed in IDEXX Laboratories is a sale by April McClain Delaney (house, MD), dated 16 Oct 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 16 Oct 2025 | April McClain Delaneyhouse · Democrat–MD | Sale | 1K USD–15K USD | 19 days |
| 04 Sep 2025 | Byron Donaldshouse · Republican–FL | Purchase | 1K USD–15K USD | 33 days |
| 07 Aug 2025 | April McClain Delaneyhouse · Democrat–MD | Sale | 1K USD–15K USD | 26 days |
| 09 Jul 2025 | April McClain Delaneyhouse · Democrat–MD | Sale | 1K USD–15K USD | 27 days |
| 15 May 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Purchase | 1K USD–15K USD | 25 days |
| 12 May 2025 | Jefferson Shrevehouse · Republican–IN | Sale | 100K USD–250K USD | 41 days |
| 09 Apr 2025 | April McClain Delaneyhouse · Democrat–MD | Purchase | 1K USD–15K USD | 23 days |
| 08 Apr 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Sale | 1K USD–15K USD | 20 days |
IDEXX Laboratories (IDXX) US federal contracts
US federal agencies committed 1.8M USD in contracts to IDEXX Laboratories (IDXX) in fiscal 2026, the year to 30 Sep 2026, against 1.6M USD the year before.
USAspending.gov
| Signed | Agency | Contract | Committed |
|---|---|---|---|
| 11 Jun 2026 | National Institutes of HealthDepartment of Health and Human Services | OD: SERVICE: ANIMAL HEALTH & DIAGNOSTIC TESTING SERVICES - SEVERABLESUPPORT- PROFESSIONAL: VETERINARY/ANIMAL CARE · 75N98026F00001 · IDEXX DISTRIBUTION, INC | 594K USD |
| 10 Apr 2026 | National Institutes of HealthDepartment of Health and Human Services | IDEXX DISTRIBUTION, INC.:1254707 [26-000422]SUPPORT- PROFESSIONAL: VETERINARY/ANIMAL CARE · 75N98026F00002 · IDEXX DISTRIBUTION, INC | 390K USD |
| 17 Mar 2026 | Animal and Plant Health Inspection ServiceDepartment of Agriculture | 190 PRV ELISA GB STRIP KITS (P/N 99-09732)LABORATORY EQUIPMENT AND SUPPLIES · 12639526F0321 · IDEXX DISTRIBUTION, INC | 153K USD |
| 28 Jan 2026 | Department of the NavyDepartment of Defense | REAGENT POWDERLABORATORY EQUIPMENT AND SUPPLIES · N0010426PBH04 | 103K USD |
| 15 Dec 2025 | National Institutes of HealthDepartment of Health and Human Services | CONTRACT FOR SEROLOGY AND PCR ASSAY TESTING SERVICESSUPPORT- PROFESSIONAL: VETERINARY/ANIMAL CARE · 75N98026F00001 · IDEXX DISTRIBUTION, INC | 230K USD |
| 23 Sep 2025 | Agricultural Research ServiceDepartment of Agriculture | IDEXX SWINE INFLUENZA VIRUS AB TESTS.LABORATORY EQUIPMENT AND SUPPLIES · 1232SA25P0452 | 111K USD |
| 21 Aug 2025 | National Institutes of HealthDepartment of Health and Human Services | CONTRACT FOR SEROLOGY AND PCR ASSAY TESTING SERVICESSUPPORT- PROFESSIONAL: VETERINARY/ANIMAL CARE · 75N98025F00010 · IDEXX DISTRIBUTION, INC | 185K USD |
| 20 Mar 2025 | Animal and Plant Health Inspection ServiceDepartment of Agriculture | PRV ELISA GB STRIP KITS (P/N99-09732) FOR KY BRUCELLOSIS LAB (ORDERING PERIOD 2)LABORATORY EQUIPMENT AND SUPPLIES · 12639525F0504 · IDEXX DISTRIBUTION, INC | 147K USD |
| 26 Feb 2025 | National Institutes of HealthDepartment of Health and Human Services | PATHOLOGY MONITORING OF AGED RODENT COLONIESSPECIAL STUDIES/ANALYSIS- ANIMAL/FISHERIES · 75N95025F00001 · IDEXX DISTRIBUTION, INC | 171K USD |
| 18 Nov 2024 | National Institutes of HealthDepartment of Health and Human Services | IDEXX DISTRIBUTION, INC.:1254707 [25-000518]SUPPORT- PROFESSIONAL: VETERINARY/ANIMAL CARE · 75N98025F00002 · IDEXX DISTRIBUTION, INC | 109K USD |
Newest first: 10 of 15 contracts. Contracts of US$100,000 or more signed since April 2022; the amount is what the government has committed so far, which grows when options are exercised. Defense Department contracts are published about 90 days after signing, so the latest year is still filling in.
What has been filed or recorded for IDEXX Laboratories (IDXX)?
The filings we hold for IDEXX Laboratories, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 4.01 USD | Revenue $1.21B |
| 30 Sep 2026 | Financials | Total assets | 3.7B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 1.9B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 4.27 USD | Revenue $1.22B |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 3.47 USD | Revenue $1.14B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 13.08 USD | Revenue $4.30B |
| 31 Dec 2025 | Financials | Revenue | 4.3B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 1.1B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 13.08 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 3.40 USD | Revenue $1.11B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 3.63 USD | Revenue $1.11B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 2.96 USD | Revenue $998M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 10.67 USD | Revenue $3.90B |
What is Reddit saying about IDEXX Laboratories (IDXX)?
Reddit mentioned IDXX 1 times in the 30 days to 21 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 21 November 2026.
30-day window, Method
How do Reddit mentions of IDEXX Laboratories (IDXX) compare with its price?
Share ↗
Which subreddits are talking about IDEXX Laboratories (IDXX)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/stocks | 100% | 1 | +0.24 |
What do people ask about IDEXX Laboratories (IDXX)?
What did IDEXX Laboratories shares close at?676.76
IDEXX Laboratories closed at 676.76 USD on 20 Nov 2026, down 1.88% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is IDEXX Laboratories’ market cap?53.3B
IDEXX Laboratories is worth 53.3B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is IDEXX Laboratories’ P/E ratio?45.6
IDEXX Laboratories has a price-to-earnings ratio of 45.6, as of 20 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is IDEXX Laboratories’ revenue?4.3B
IDEXX Laboratories reported revenue of 4.3B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have IDEXX Laboratories insiders bought or sold shares recently?5 sales
In the 90 days to 22 Nov 2026, IDEXX Laboratories insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 14 Feb 2026, show no open-market purchase. A further 7 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own IDEXX Laboratories?12 of 45
12 of the 45 funds we track reported a IDEXX Laboratories position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Fundsmith, Millennium Management and Point72 Asset Management. See Funds
Have members of Congress traded IDEXX Laboratories?14 trades
Yes. 14 trades in IDEXX Laboratories appear in the congressional disclosures we hold; the latest is a sale by April McClain Delaney (House, MD) dated 16 Oct 2025, filed 4 Nov 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did IDEXX Laboratories last report earnings?4.01
IDEXX Laboratories last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 4.01 USD; no next date is announced in SEC filings yet. See Filings
Does IDEXX Laboratories have government contracts?1.8M
Yes. US federal agencies committed 1.8M USD in contracts to it in fiscal 2026, the year to 30 Sep 2026 (USAspending.gov). See Contracts
What is Reddit saying about IDEXX Laboratories?0 mentions
IDEXX Laboratories was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Byron Donalds: United States Congress, Public domain; Jefferson Shreve: House Creative Services, Public domain; Robert P. Bresnahan, Jr.: House Creative Services, Public domain; April McClain Delaney: Ike Hayman, House Creative Services, Public domain.
- House disclosuresU.S. House of Representatives financial disclosures
- USAspendingUSAspending.gov (U.S. Department of the Treasury), federal prime contract awards
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Idexx_Laboratories